Acadia Pharmaceuticals to Present at Upcoming Investor Conferences

Rhea-AI Summary

Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) will participate in two upcoming investor conferences. The BofA Securities 2022 Healthcare Conference features a fireside chat on May 10, 2022, at 3:20 p.m. PT in Las Vegas, NV. The RBC Capital Markets Global Healthcare Conference will include a fireside chat on May 18, 2022, at 4:05 p.m. ET in New York, NY. Live webcasts can be accessed on the company’s website, with recordings available for a month post-event.

Acadia focuses on neuroscience breakthroughs, notably for Parkinson's disease psychosis and dementia-related psychosis.

SAN DIEGO--(BUSINESS WIRE)-- Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that it will participate at the following upcoming investor conferences:

BofA Securities 2022 Healthcare Conference
Fireside Chat: Tuesday, May 10, 2022 at 3:20 p.m. Pacific Time in Las Vegas, NV

2022 RBC Capital Markets Global Healthcare Conference
Fireside Chat: Wednesday, May 18, 2022 at 4:05 p.m. Eastern Time in New York, NY

Live webcasts of the presentations will be accessible on the company’s website, www.acadia-pharm.com, under the investors section and an archived recording will be available on the website for approximately one month following each presentation.

About Acadia Pharmaceuticals

Acadia is advancing breakthroughs in neuroscience to elevate life. For more than 25 years we have been working at the forefront of healthcare to bring vital solutions to people who need them most. We developed and commercialized the first and only approved therapy for hallucinations and delusions associated with Parkinson’s disease psychosis. Our late-stage development efforts are focused on treating psychosis in patients with dementia, the negative symptoms of schizophrenia and Rett syndrome. Our early-stage development efforts are focused on novel approaches to pain management, cognition and neuropsychiatric symptoms in central nervous system disorders. For more information, visit us at www.acadia-pharm.com and follow us on LinkedIn and Twitter.

View source version on businesswire.com: https://www.businesswire.com/news/home/20220503006067/en/

Media Contact:

Acadia Pharmaceuticals Inc.

Deb Kazenelson

(818) 395-3043

media@acadia-pharm.com

Investor Contact:

Acadia Pharmaceuticals Inc.

Mark Johnson, CFA

(858) 261-2771

ir@acadia-pharm.com

Source: Acadia Pharmaceuticals Inc.

FAQ

What conferences will Acadia Pharmaceuticals be attending in May 2022?

Acadia Pharmaceuticals will participate in the BofA Securities 2022 Healthcare Conference on May 10 and the RBC Capital Markets Global Healthcare Conference on May 18, 2022.

When is Acadia's fireside chat at the BofA Securities Conference?

The fireside chat at the BofA Securities Conference will take place on May 10, 2022, at 3:20 p.m. Pacific Time.

What is the date and time for Acadia's presentation at the RBC Capital Markets Conference?

Acadia's presentation at the RBC Capital Markets Global Healthcare Conference is scheduled for May 18, 2022, at 4:05 p.m. Eastern Time.

Where can I watch the live webcasts of Acadia Pharmaceuticals' presentations?

The live webcasts of Acadia Pharmaceuticals' presentations can be accessed on their website, particularly under the investors section.

What areas of research does Acadia Pharmaceuticals focus on?

Acadia Pharmaceuticals focuses on breakthroughs in neuroscience, including treatments for Parkinson's disease psychosis and dementia-related psychosis.